Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,286,956
+$531,740 QoQ
Shares Held
8,578
+4.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#296
of 594 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CIBC Bancorp USA Inc. holds $1,065,631,969 across 20 Diagnostics & Research names. GH ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
544,854 | $273,168,000 | |
| 2 | DHR |
Danaher Corp /De/
|
1,322,604 | $251,929,609 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
346,891 | $182,617,297 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
747,031 | $144,341,328 | |
| 5 | ILMN |
Illumina, Inc.
|
298,654 | $52,512,331 | |
| 6 | NTRA |
Natera, Inc.
|
152,917 | $41,509,318 | |
| 7 | ICLR |
Icon PLC
|
231,237 | $40,168,178 | |
| 8 | RVTY |
Revvity, Inc.
|
261,625 | $29,108,397 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,286,956 | 8,578 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $755,216 | 8,176 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $795,620 | 12,734 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||